Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Passage Bio
Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)
September 16, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Welcomes Tom Kassberg to Board of Directors
September 10, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 30, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
August 08, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Participate in Upcoming Investor Conferences
August 06, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
August 01, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
July 16, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 14, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 22, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
March 04, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Participate in Upcoming Investor Conferences
February 27, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
December 20, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
November 17, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 13, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
October 30, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
September 25, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
August 07, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
August 07, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Participate in Upcoming Investor Conferences
August 01, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
July 31, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
May 11, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 17, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
March 27, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
March 06, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Passage Bio
Via
GlobeNewswire
Tickers
PASG
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright